Mitochondrial involvement in genetically determined transition metal toxicity I. Iron toxicity.

[1]  A. Brownlie,et al.  Mitoferrin is essential for erythroid iron assimilation , 2006, Nature.

[2]  T. Ganz,et al.  Iron imports. IV. Hepcidin and regulation of body iron metabolism. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[3]  Christos T. Chasapis,et al.  A NMR Study of the Interaction of a Three-domain Construct of ATP7A with Copper(I) and Copper(I)-HAH1 , 2005, Journal of Biological Chemistry.

[4]  L. V. Puchkova,et al.  [Identification of the rat ceruloplasmin mRNA isoform putative coded of a protein localized in mitochondria]. , 2005, Molekuliarnaia biologiia.

[5]  L. V. Puchkova,et al.  Identification of the Putative mRNA Coding for a Mitochondrial Isoform of Rat Ceruloplasmin , 2005, Molecular Biology.

[6]  V. Vassiliev,et al.  Ceruloplasmin in neurodegenerative diseases , 2005, Brain Research Reviews.

[7]  G. Brewer.  Anticopper therapy against cancer and diseases of inflammation and fibrosis. , 2005, Drug discovery today.

[8]  M. Núñez,et al.  Iron and copper metabolism. , 2005, Molecular aspects of medicine.

[9]  R. Beynon,et al.  The greater susceptibility of North Ronaldsay sheep compared with Cambridge sheep to copper-induced oxidative stress, mitochondrial damage and hepatic stellate cell activation. , 2005, Journal of comparative pathology.

[10]  C. Keen,et al.  Copper, oxidative stress, and human health. , 2005, Molecular aspects of medicine.

[11]  S. Kaler,et al.  Downregulation of myelination, energy, and translational genes in Menkes disease brain. , 2005, Molecular genetics and metabolism.

[12]  Jian Cai,et al.  Metallothionein transfers zinc to mitochondrial aconitase through a direct interaction in mouse hearts. , 2005, Biochemical and biophysical research communications.

[13]  D. Butterfield,et al.  Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia , 2005, Journal of the Neurological Sciences.

[14]  T. Rouault,et al.  Iron–sulphur cluster biogenesis and mitochondrial iron homeostasis , 2005, Nature Reviews Molecular Cell Biology.

[15]  M. Beal,et al.  Mutant Superoxide Dismutase 1 Forms Aggregates in the Brain Mitochondrial Matrix of Amyotrophic Lateral Sclerosis Mice , 2005, The Journal of Neuroscience.

[16]  D. Richardson,et al.  Iron trafficking in the mitochondrion: novel pathways revealed by disease. , 2005, Blood.

[17]  G. Rotilio,et al.  Copper-dependent toxicity in SH-SY5Y neuroblastoma cells involves mitochondrial damage. , 2005, Biochemical and biophysical research communications.

[18]  Klevay Lm.  Ischemic heart disease as deficiency disease. , 2004 .

[19]  J. Prohaska,et al.  Cu, Zn-Superoxide Dismutase is Lower and Copper Chaperone CCS is Higher in Erythrocytes of Copper-Deficient Rats and Mice , 2004, Experimental biology and medicine.

[20]  Heather A. O'Neill,et al.  Frataxin Acts as an Iron Chaperone Protein to Modulate Mitochondrial Aconitase Activity , 2004, Science.

[21]  M. Cazzola,et al.  Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. , 2004, Blood.

[22]  C. Sheline,et al.  Cu2+ toxicity inhibition of mitochondrial dehydrogenases in vitro and in vivo , 2004, Annals of neurology.

[23]  J. Prohaska,et al.  Intracellular copper transport in mammals. , 2004, The Journal of nutrition.

[24]  L. V. Puchkova,et al.  Age-Related Features of Ceruloplasmin Biosynthesis and Distribution in Rats , 2004, Russian Journal of Developmental Biology.

[25]  M. Hentze,et al.  Balancing Acts Molecular Control of Mammalian Iron Metabolism , 2004, Cell.

[26]  J. Valentine,et al.  Mechanisms for activating Cu- and Zn-containing superoxide dismutase in the absence of the CCS Cu chaperone. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Franklin,et al.  Metallothionein can function as a chaperone for zinc uptake transport into prostate and liver mitochondria. , 2004, Journal of inorganic biochemistry.

[28]  M. Cazzola,et al.  Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R). , 2004, Blood.

[29]  G. Rotilio,et al.  Mitochondrial Dysfunction in Neurodegenerative Diseases Associated with Copper Imbalance , 2004, Neurochemical Research.

[30]  C. Wijmenga,et al.  Molecular regulation of copper excretion in the liver , 2004, Proceedings of the Nutrition Society.

[31]  A. Jayasurya,et al.  Metallothioneins in human tumors and potential roles in carcinogenesis. , 2003, Mutation research.

[32]  M. Kruszewski,et al.  Labile iron pool: the main determinant of cellular response to oxidative stress. , 2003, Mutation research.

[33]  M. L’Abbé,et al.  Copper Modulates the Degradation of Copper Chaperone for Cu,Zn Superoxide Dismutase by the 26 S Proteosome* , 2003, Journal of Biological Chemistry.

[34]  E. D. Harris.  Basic and clinical aspects of copper. , 2003 .

[35]  I. Fridovich,et al.  Mutant Cu,Zn superoxide dismutases and familial amyotrophic lateral sclerosis: evaluation of oxidative hypotheses. , 2003, Free radical biology & medicine.

[36]  Z. Harris,et al.  Genetic defects in copper metabolism. , 2003, The Journal of nutrition.

[37]  J. Mercer,et al.  Molecular and cellular aspects of copper transport in developing mammals. , 2003, The Journal of nutrition.

[38]  D. Winge,et al.  Assembly of cytochrome c oxidase within the mitochondrion. , 2003, Accounts of chemical research.

[39]  P. Fox.  The copper-iron chronicles: The story of an intimate relationship , 2003, Biometals.

[40]  M. Cazzola,et al.  Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. , 2003, Blood.

[41]  D. Richardson.  Friedreich’s ataxia: iron chelators that target the mitochondrion as a therapeutic strategy? , 2003, Expert opinion on investigational drugs.

[42]  D. Templeton.  The importance of trace element speciation in biomedical science , 2003, Analytical and bioanalytical chemistry.

[43]  C. Vulpe,et al.  The ceruloplasmin homolog hephaestin and the control of intestinal iron absorption. , 2002, Blood cells, molecules & diseases.

[44]  M. Cazzola,et al.  Mitochondrial ferritin: a new player in iron metabolism. , 2002, Blood cells, molecules & diseases.

[45]  Or Kakhlon,et al.  The labile iron pool: characterization, measurement, and participation in cellular processes(1). , 2002, Free radical biology & medicine.

[46]  B. Bacon,et al.  Iron Toxicity and Chelation Therapy , 2002, International journal of hematology.

[47]  J. Gitlin,et al.  The copper-iron connection: hereditary aceruloplasminemia. , 2002, Seminars in hematology.

[48]  M. Marra,et al.  Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation. , 2002, Blood.

[49]  C. Sheline,et al.  Cofactors of mitochondrial enzymes attenuate copper‐induced death in vitro and in vivo , 2002, Annals of neurology.

[50]  L. Powell,et al.  Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. , 2002, Blood.

[51]  Aamir Ahmad,et al.  Bilirubin/biliverdin-Cu(II) induced DNA breakage; reaction mechanism and biological significance. , 2002, Toxicology letters.

[52]  J. Eaton,et al.  Interactions of copper with glycated proteins: Possible involvement in the etiology of diabetic neuropathy , 2002, Molecular and Cellular Biochemistry.

[53]  J. Eaton,et al.  Molecular bases of cellular iron toxicity. , 2002, Free radical biology & medicine.

[54]  P. Rustin,et al.  Cytochrome oxidase in health and disease. , 2002, Gene.

[55]  R. Hider,et al.  Iron: an essential but potentially harmful nutrient , 2002, European journal of clinical investigation.

[56]  P. Ponka.  Iron Utilization in Erythrocyte Formation and Hemoglobin Synthesis , 2002 .

[57]  D. Templeton.  Molecular and Cellular Iron Transport , 2002 .

[58]  D. Templeton,et al.  Transport of Non-Transferrin-Bound Iron by Hepatocytes , 2002 .

[59]  F. Petrat,et al.  The Chelatable Iron Pool in Living Cells: A Methodically Defined Quantity , 2002, Biological chemistry.

[60]  I. Fridovich,et al.  Subcellular Distribution of Superoxide Dismutases (SOD) in Rat Liver , 2001, The Journal of Biological Chemistry.

[61]  M. Kondoh,et al.  Specific induction of metallothionein synthesis by mitochondrial oxidative stress. , 2001, Life sciences.

[62]  P. Arosio,et al.  A Human Mitochondrial Ferritin Encoded by an Intronless Gene* , 2001, The Journal of Biological Chemistry.

[63]  H. Schipper,et al.  Proinflammatory cytokines promote glial heme oxygenase‐1 expression and mitochondrial iron deposition: implications for multiple sclerosis , 2001, Journal of neurochemistry.

[64]  F. Palau,et al.  Friedreich's ataxia and frataxin: molecular genetics, evolution and pathogenesis (Review). , 2001, International journal of molecular medicine.

[65]  B. Ye,et al.  Zinc metallothionein imported into liver mitochondria modulates respiration , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[66]  M. Schaefer,et al.  Hepatic iron overload in aceruloplasminaemia , 2000, Gut.

[67]  T. Rouault,et al.  Distinct iron–sulfur cluster assembly complexes exist in the cytosol and mitochondria of human cells , 2000, The EMBO journal.

[68]  P. Patel,et al.  Human frataxin maintains mitochondrial iron homeostasis in Saccharomyces cerevisiae. , 2000, Human molecular genetics.

[69]  Peter Schulz-Knappe,et al.  LEAP‐1, a novel highly disulfide‐bonded human peptide, exhibits antimicrobial activity , 2000, FEBS letters.

[70]  J. Cooper,et al.  Oxidative-phosphorylation defects in liver of patients with Wilson's disease , 2000, The Lancet.

[71]  S. Seki,et al.  Proteome analysis of rat hepatic stellate cells , 2000, Hepatology.

[72]  S. Abboud,et al.  A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism* , 2000, The Journal of Biological Chemistry.

[73]  C. Krebs,et al.  IscU as a scaffold for iron-sulfur cluster biosynthesis: sequential assembly of [2Fe-2S] and [4Fe-4S] clusters in IscU. , 2000, Biochemistry.

[74]  H. Schipper,et al.  Heme oxygenase-1 induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides. , 2000, Cellular and molecular biology.

[75]  D. Ceccarelli,et al.  Iron-Induced Oxidant Stress Leads to Irreversible Mitochondrial Dysfunctions and Fibrosis in the Liver of Chronic Iron-Dosed Gerbils. The Effect of Silybin , 2000, Journal of bioenergetics and biomembranes.

[76]  M. Koenig,et al.  Recent advances in the molecular pathogenesis of Friedreich ataxia. , 2000, Human molecular genetics.

[77]  J. Pourahmad,et al.  A comparison of hepatocyte cytotoxic mechanisms for Cu2+ and Cd2+. , 2000, Toxicology.

[78]  W. Sly,et al.  Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[79]  R J Simpson,et al.  A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. , 2000, Molecular cell.

[80]  J. Cooper,et al.  Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. , 2000, Human molecular genetics.

[81]  R Williamson,et al.  Review articles Friedreich ataxia: an overview , 1999 .

[82]  E. van den Berg,et al.  Mitochondrial disruption and limited apoptosis of erythroblasts are associated with high risk myelodysplasia. An ultrastructural analysis. , 1999, Leukemia research.

[83]  R. Lill,et al.  The Essential Role of Mitochondria in the Biogenesis of Cellular Iron-Sulfur Proteins , 1999, Biological chemistry.

[84]  M. Ohta,et al.  A Case of Hereditary Ceruloplasmin Deficiency with Iron Deposition in the Brain Associated with Chorea, Dementia, Diabetes mellitus and Retinal Pigmentation: Administration of Fresh-Frozen Human Plasma , 1999, European Neurology.

[85]  S. Tabrizi,et al.  Secondary abnormalities of mitochondrial DNA associated with neurodegeneration. , 1999, Biochemical Society symposium.

[86]  H. Koeffler,et al.  Molecular Cloning of Transferrin Receptor 2 , 1999, The Journal of Biological Chemistry.

[87]  Masayuki Yamamoto,et al.  A novel mutation of the erythroid‐specific δ‐aminolaevulinate synthase gene in a patient with X‐linked sideroblastic anaemia , 1999, British journal of haematology.

[88]  M. Sogorb,et al.  Dichlorophenyl phosphoramidates as substrates for avian and mammalian liver phosphotriesterases: activity levels, calcium dependence and stereospecificity. , 1999, Chemico-biological interactions.

[89]  M. Delatycki,et al.  Direct evidence that mitochondrial iron accumulation occurs in Friedreich ataxia , 1999, Annals of neurology.

[90]  L. Bernier,et al.  Mitochondrial Iron Sequestration in Dopamine‐Challenged Astroglia: Role of Heme Oxygenase‐1 and the Permeability Transition Pore , 1999, Journal of neurochemistry.

[91]  A. Hutchinson,et al.  Mutation of a Putative Mitochondrial Iron Transporter Gene (ABC7) in X-Linked Sideroblastic Anemia and Ataxia (XLSA/A) , 1999, Human molecular genetics.

[92]  Gregory J. Anderson,et al.  Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse , 1999, Nature Genetics.

[93]  B. Bergamasco,et al.  Psychiatric symptoms as late onset of Wilson's disease: neuroradiological findings, clinical features and treatment , 1999, The Italian Journal of Neurological Sciences.

[94]  G. Link,et al.  Cardioprotective effect of alpha-tocopherol, ascorbate, deferoxamine, and deferiprone: mitochondrial function in cultured, iron-loaded heart cells. , 1999, The Journal of laboratory and clinical medicine.

[95]  I. Mavelli,et al.  Decrease of cytochrome c oxidase protein in heart mitochondria of copper-deficient rats , 1998, Biometals.

[96]  H. Schipper,et al.  Astrocyte Mitochondria: A Substrate for Iron Deposition in the Aging Rat Substantia Nigra , 1998, Experimental Neurology.

[97]  R. Williamson,et al.  The correlation of clinical phenotype in Friedreich ataxia with the site of point mutations in the FRDA gene , 1998, Neurogenetics.

[98]  G. Link,et al.  Pathophysiology of Iron Overload a , 1998, Annals of the New York Academy of Sciences.

[99]  T. Fujiwara,et al.  Cloning and chromosomal mapping of a novel ABC transporter gene (hABC7), a candidate for X-linked sideroblastic anemia with spinocerebellar ataxia , 1998, Journal of Human Genetics.

[100]  M. Cooper,et al.  Localization of the Wilson's disease protein product to mitochondria. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[101]  J. Gitlin,et al.  Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. , 1998, The American journal of clinical nutrition.

[102]  G. Link,et al.  Mitochondrial respiratory enzymes are a major target of iron toxicity in rat heart cells. , 1998, The Journal of laboratory and clinical medicine.

[103]  M. Hambidge,et al.  Clinical conditions altering copper metabolism in humans. , 1998, The American journal of clinical nutrition.

[104]  E. Bradbury,et al.  GAA instability in Friedreich's Ataxia shares a common, DNA-directed and intraallelic mechanism with other trinucleotide diseases. , 1998, Molecular cell.

[105]  B. Guiard,et al.  The ABC transporter Atm1p is required for mitochondrial iron homeostasis , 1997, FEBS letters.

[106]  B. Van Houten,et al.  Preferential mitochondrial DNA injury caused by glucose oxidase as a steady generator of hydrogen peroxide in human fibroblasts. , 1997, Mutation research.

[107]  F. Kuipers,et al.  Differences in hepatic processing of dietary and intravenously administered copper in rats , 1997, Hepatology.

[108]  R. Wildman,et al.  Newer Findings on a Unified Perspective of Copper Restriction and Cardiomyopathy 1 , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[109]  D. Pessayre,et al.  Premature oxidative aging of hepatic mitochondrial DNA in Wilson's disease. , 1997, Gastroenterology.

[110]  M. Pandolfo,et al.  Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. , 1997, Science.

[111]  R. Wolff,et al.  The Hemochromatosis Founder Mutation in HLA-H Disrupts β2-Microglobulin Interaction and Cell Surface Expression* , 1997, The Journal of Biological Chemistry.

[112]  R. Palmiter,et al.  Metallothioneins in brain--the role in physiology and pathology. , 1997, Toxicology and applied pharmacology.

[113]  B. Van Houten,et al.  Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[114]  A Dürr,et al.  Clinical and genetic abnormalities in patients with Friedreich's ataxia. , 1996, The New England journal of medicine.

[115]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[116]  D. Richardson,et al.  Distribution of iron in reticulocytes after inhibition of heme synthesis with succinylacetone: examination of the intermediates involved in iron metabolism. , 1996, Blood.

[117]  S. Fucharoen,et al.  Liver injury due to iron overload in thalassemia: histopathologic and ultrastructural studies , 1996, Biometals.

[118]  P. Patel,et al.  Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.

[119]  G. Link,et al.  Role of iron in the potentiation of anthracycline cardiotoxicity: identification of heart cell mitochondria as a major site of iron-anthracycline interaction. , 1996, The Journal of laboratory and clinical medicine.

[120]  I. Sternlieb,et al.  An array of mitochondrial alterations in the hepatocytes of long‐evans cinnamon rats , 1995, Hepatology.

[121]  G. Gyapay,et al.  The Friedreich ataxia critical region spans a 150-kb interval on chromosome 9q13. , 1995, American journal of human genetics.

[122]  H. Morita,et al.  Hereditary ceruloplasmin deficiency with hemosiderosis: A clinicopathological study of a japanese family , 1995, Annals of neurology.

[123]  H. Schipper,et al.  A Cellular Stress Model for the Sequestration of Redox‐Active Glial Iron in the Aging and Degenerating Nervous System , 1995, Journal of neurochemistry.

[124]  B. Garty,et al.  Myopathy, lactic acidosis, and sideroblastic anemia: a new syndrome. , 1995, American journal of medical genetics.

[125]  B. Neuschwander‐Tetri,et al.  Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. , 1994, Gastroenterology.

[126]  Y. Wada,et al.  Studies on familial hypotransferrinemia: unique clinical course and molecular pathology. , 1993, American journal of human genetics.

[127]  R. Sokol,et al.  Abnormal hepatic mitochondrial respiration and cytochrome C oxidase activity in rats with long-term copper overload. , 1993, Gastroenterology.

[128]  H. Faille,et al.  Accumulation of iron in erythroblasts of patients with erythropoietic protoporphyria , 1993, European journal of clinical investigation.

[129]  B. Halliwell,et al.  Biologically relevant metal ion‐dependent hydroxyl radical generation An update , 1992, FEBS letters.

[130]  I. A. Skulskii,et al.  Interaction of Cu+ with mitochondria. , 1991, Acta chemica Scandinavica.

[131]  G. Waldrop,et al.  Effect of albumin on net copper accumulation by fibroblasts and hepatocytes. , 1990, The American journal of physiology.

[132]  J. Kumaratilake,et al.  Intracellular distribution of copper in the liver of copper-loaded sheep--a subcellular fractionation study. , 1989, Journal of comparative pathology.

[133]  C. Craven,et al.  Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[134]  Y. Ueda,et al.  delta-Aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia. Hypercatabolism caused by the increased susceptibility to the controlling protease. , 1979, The Journal of clinical investigation.

[135]  D. Massart,et al.  The determination of Cu, Zn, and Mn in subcellular rat liver fractions. , 1977, Analytical biochemistry.

[136]  D. Loukopoulos,et al.  Role of Copper in Mitochondrial Iron Metabolism , 1976 .

[137]  T. Sourkes,et al.  Intracellular distribution of copper in the liver during chronic administration of copper sulfate to the rat. , 1971, Toxicology and applied pharmacology.

[138]  J. Grasso,et al.  A Comparative Electron Microscopic Study of Refractory and Alcoholic Sideroblastic Anaemia , 1969, British journal of haematology.

[139]  G. Papanikolaou,et al.  Prevalence of the G320V mutation of the HJV gene, associated with juvenile hemochromatosis, in Greece. , 2004, Haematologica.

[140]  D. Girelli,et al.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis , 2003, Nature Genetics.

[141]  J. Tolmie,et al.  Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation. , 2000, Blood.

[142]  Harris Ed.  Ceruloplasmin and iron: vindication after 30 years. , 1999 .

[143]  P. Patel,et al.  The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. , 1998, American journal of human genetics.

[144]  P. Ponka.  Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. , 1997, Blood.

[145]  P. Ponka.  Tissue-Specific Regulation of Iron Metabolism and Heme Synthesis: Distinct Control Mechanisms in Erythroid Cells , 1997 .

[146]  Giuseppe Di Fazio,et al.  Interaction between Cu2+ ions and cholic acid derivatives followed by polarography. , 1995, Journal of pharmaceutical sciences.

[147]  B. Halliwell,et al.  Role of free radicals and catalytic metal ions in human disease: an overview. , 1990, Methods in enzymology.

[148]  G. Sutherland,et al.  Erythroid 5-aminolevulinate synthase is located on the X chromosome. , 1990, American journal of human genetics.

[149]  D. Weatherall,et al.  Iron-chelating therapy. , 1988, Critical reviews in clinical laboratory sciences.

[150]  E. Russanov,et al.  Studies on lipid peroxidation in rat liver by copper deficiency. , 1981, The International journal of biochemistry.

[151]  T. Tephly,et al.  A possible role of copper in the regulation of heme biosynthesis through ferrochelatase. , 1975, Advances in experimental medicine and biology.

[152]  M. Losowsky,et al.  Microspectrophotometric and electron microscopic studies of bone marrow in hereditary sideroblastic anaemia. , 1971, Acta haematologica.